Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -16.258% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCO[C@@H]1OC(C(=O)N2CCN(C)CC2)=C[C@H](c2csc3ccccc23)[C@H]1CCCO
(b) CCN(C(=O)COC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1OC)C1CCS(=O)(=O)C1
Answer: b. CCN(C(=O)COC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1OC)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)COC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1OC)C1CCS(=O)(=O)C1
CCN(C(=O)COC(=O)c1cc(S(=O)(=O)N2CCc3ccccc32)ccc1OC)C1CCS(=O)(=O)C1
[2-[(1,1-dioxothiolan-3-yl)-ethylamino]-2-oxoethyl]5-(2,3-dihydroindol-1-ylsulfonyl)-2-methoxybenzoate